Smokers run increased risk of developing anti-natalizumab antibodies.
about
Antidrug Antibodies: B Cell Immunity Against TherapyThe Swedish MS registry – clinical support tool and scientific resource.Modifiable environmental factors in multiple sclerosis.What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence.Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases.
P2860
Smokers run increased risk of developing anti-natalizumab antibodies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Smokers run increased risk of developing anti-natalizumab antibodies.
@en
Smokers run increased risk of developing anti-natalizumab antibodies.
@nl
type
label
Smokers run increased risk of developing anti-natalizumab antibodies.
@en
Smokers run increased risk of developing anti-natalizumab antibodies.
@nl
prefLabel
Smokers run increased risk of developing anti-natalizumab antibodies.
@en
Smokers run increased risk of developing anti-natalizumab antibodies.
@nl
P2093
P2860
P356
P1476
Smokers run increased risk of developing anti-natalizumab antibodies.
@en
P2093
A Fogdell-Hahn
A K Hedström
Jan Hillert
M Lundkvist Ryner
P2860
P304
P356
10.1177/1352458513515086
P577
2013-12-05T00:00:00Z